Allspring Global Investments Holdings LLC Acquires 38,979 Shares of Danaher Corporation $DHR

Allspring Global Investments Holdings LLC increased its holdings in Danaher Corporation (NYSE:DHRFree Report) by 8.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 485,461 shares of the conglomerate’s stock after buying an additional 38,979 shares during the period. Allspring Global Investments Holdings LLC owned about 0.07% of Danaher worth $111,850,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. JPL Wealth Management LLC purchased a new stake in shares of Danaher during the 3rd quarter worth $25,000. WFA of San Diego LLC bought a new position in Danaher in the second quarter worth about $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher during the second quarter valued at about $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher during the third quarter valued at about $27,000. Finally, TruNorth Capital Management LLC bought a new stake in shares of Danaher in the 3rd quarter valued at about $28,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 11.20% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of analyst reports. Jefferies Financial Group lifted their price objective on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. The Goldman Sachs Group lowered their target price on shares of Danaher from $270.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 29th. Wells Fargo & Company lifted their price target on shares of Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Robert W. Baird set a $251.00 price target on Danaher in a research report on Thursday, January 29th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Nineteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $253.55.

Read Our Latest Stock Report on Danaher

Danaher Stock Up 3.0%

DHR stock opened at $189.33 on Wednesday. The stock has a market capitalization of $133.99 billion, a PE ratio of 37.57, a price-to-earnings-growth ratio of 2.49 and a beta of 0.93. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The firm has a 50 day moving average of $207.36 and a 200 day moving average of $214.61.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same quarter last year, the company posted $2.14 earnings per share. The business’s quarterly revenue was up 4.6% on a year-over-year basis. Sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a $0.40 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio (DPR) is 31.75%.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.